Last reviewed · How we verify
somatropin - GH treated cohort — Competitive Intelligence Brief
marketed
Live · refreshed every 30 min
Target snapshot
somatropin - GH treated cohort (somatropin-gh-treated-cohort) — Pfizer Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| somatropin - GH treated cohort TARGET | somatropin-gh-treated-cohort | Pfizer Inc. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- somatropin - GH treated cohort CI watch — RSS
- somatropin - GH treated cohort CI watch — Atom
- somatropin - GH treated cohort CI watch — JSON
- somatropin - GH treated cohort alone — RSS
Cite this brief
Drug Landscape (2026). somatropin - GH treated cohort — Competitive Intelligence Brief. https://druglandscape.com/ci/somatropin-gh-treated-cohort. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab